
Miranix 50 Tablet ER
Marketer
Ajanta Pharma Ltd
Salt Composition
Mirabegron (50mg)
Overview Miranix 50 Tablet ER
Extended-release Miranix 50mg tablets alleviate overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always follow your doctor's prescribed dosage and duration. Miranix 50mg ER tablets may be taken with or without food; swallow whole, avoiding crushing or chewing. Discontinue use only under medical supervision, as abrupt cessation may exacerbate symptoms. Complete the prescribed course for optimal therapeutic effect. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your physician promptly. Prior to treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding status. Individuals with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.
Uses of Miranix 50 Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Miranix 50 Tablet ER:
Consume Miranix 50 ER Tablet as directed by your physician, adhering precisely to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. While it can be taken with or without food, consistent daily timing is recommended for optimal results.
Common Side effects of Miranix 50 Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Miranix 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Miranix 50 ER Tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency in timing is recommended.
How Miranix 50 Tablet ER works:
Extended-release Miranix 50mg tablets contain a beta-3 adrenergic agonist. Their mechanism involves bladder receptor stimulation, resulting in detrusor muscle relaxation and reduced urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Miranix 50 Tablet ER concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Extended-release Miranix 50mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Miranix 50mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Miranix 50 ER tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Miranix 50 ER tablets. Dosage modification for Miranix 50 ER tablets may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Miranix 50 Tablet ER cautiously, potentially requiring dose modification. Consult a physician for guidance. Miranix 50 Tablet ER is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Miranix 50 Tablet ER :
Should you forget a Miranix 50 ER Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Miranix 50 Tablet ER
| Label | Value |
|---|---|
| Type of Compound | Aromatic amide |
| Addictive | None. |
| Treatment Category | The study of the urinary tract and male reproductive system. |
| Mechanism of Action | Specific beta-3 adrenergic receptor stimulant (Urinary) |
